

2-(Chloromethyl)-4-methylquinazoline (CAS 109113-72-6) is a pivotal building block in the API intermediates market, primarily utilized as a key precursor for the synthesis of Linagliptin and other complex quinazoline-based therapeutics requiring high purity fine chemicals (Pharma/API purity 99% | General Industry purity 98%) to ensure precise crystalline morphology. Linagliptin Intermediate A serves as a high-performance substrate in the evolving CDMO landscape, where global sourcing shifts have increased the demand for custom synthesis services that offer rigorous impurity profiling and analytical validation to meet stringent regulatory standards. Quinazoline, 2-(chloromethyl)-4-methyl- remains a preferred choice for advanced process development among any bulk chemical supplier, reflecting a growing industry requirement for reliable precursors that optimize yields in large-scale commercial manufacturing while maintaining strict environmental compliance. We are an globally established 2-(Chloromethyl)-4-methylquinazoline intermediates supplier with >= 99% purity, ensuring minimal carry-over of impurities in the final API, and a broad range of various pharmaceutical intermediates for API manufacturers and finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting 2-(Chloromethyl)-4-methylquinazoline COA/TDS/SDS region-specific regulatory support. reliable lead times, worldwide supply chain capabilities

2-(Chloromethyl)-4-methylquinazoline (CAS 109113-72-6) is a pivotal building block in the API intermediates market, primarily utilized as a key precursor for the synthesis of Linagliptin and other complex quinazoline-based therapeutics requiring high purity fine chemicals (Pharma/API purity 99% | General Industry purity 98%) to ensure precise crystalline morphology. Linagliptin Intermediate A serves as a high-performance substrate in the evolving CDMO landscape, where global sourcing shifts have increased the demand for custom synthesis services that offer rigorous impurity profiling and analytical validation to meet stringent regulatory standards. Quinazoline, 2-(chloromethyl)-4-methyl- rem...

Chemical Properties & Specifications
P203, P260, P261, P264, P264+P265, P270, P271, P272, P273, P280, P284, P301+P310+P330, P301+P317, P301+P330+P331, P302+P352, P303+P361+P353, P304+P340, P304+P340+P310, P305+P351+P338, P305+P351+P338+P310, P305+P354+P338, P310, P317, P318, P321, P330, P333+P317, P362+P364, P363, P391, P403+P233, P405, and P501
Acute Tox. 4 (100%)
Skin Sens. 1A (100%)
A building block used for the preparation of Linagliptin and its related substances, which are utilized as dipeptidyl peptidase-4 (DPP-4) inhibitors in the treatment of type 2 diabetes
A versatile heterocyclic intermediate used in the development of novel therapeutic agents, particularly in cancer research for the synthesis of 4-anilinoquinazoline derivatives and other biologically active compounds
A functionalized quinazoline derivative explored in the formulation of specialized herbicides and pesticides to target specific plant pathways and improve crop yields
A high-purity chemical used as a reference material for identifying and quantifying impurities in pharmaceutical manufacturing and quality control processes.
2-(Chloromethyl)-4-methylquinazoline is a heterocyclic building block and versatile chemical intermediate primarily used in the synthesis of pharmaceuticals like Linagliptin for type 2 diabetes and in the development of anticancer agents
This compound is widely utilized in the pharmaceutical, agrochemical, and material science industries for drug discovery, herbicide development, and the creation of specialized polymers
It is a solid powder or crystal, typically used in organic synthesis protocols and compatible with liquid-phase reactions involving nucleophilic substitution
Standard specifications include CAS number 109113-72-6, a purity of ≥98%, and available documentation such as COA, TDS, impurity reports, and regulatory compliance documents
Scimplify has capabilities for global distribution and custom synthesis through an integrated network of manufacturers and logistics partners with reliable lead time
The product is export ready with a standard MOQ starting from 100 kgs, with lead times for international customers depending on the shipping destination and specific grade.
Category : Pharmaceutical Actives & Precursors
Sub-Category : Active Pharmaceutical Ingredients (APIs)
Description : Calcium acetate monohydrate (CAS No: 5743-26-0) occupies a critical position in the global specialit...
Category : Pharmaceutical Actives & Precursors
Sub-Category : Intermediates & Precursors
Description : P-Nitrobenzoyl Chloride (CAS 122-04-3) is a critical building block in the API intermediates market,...